.Statement of Comprehensive Income
Difficulty: Beginner
Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
Bristol-Myers Squibb Co., Consolidated Statement of Comprehensive Income
USD $ in millions
| 12 months ended | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| | Net earnings | ||||||||||
| | Derivatives qualifying as cash flow hedges | ||||||||||
| | Pension and postretirement benefits | ||||||||||
| | Available-for-sale securities | ||||||||||
| | Foreign currency translation | ||||||||||
| | Other comprehensive income (loss) | | | | | | |||||
| | Comprehensive income | | | | | | |||||
| | Comprehensive income (loss) attributable to noncontrolling interest | ||||||||||
| | Comprehensive income attributable to BMS | | | | | |
| Item | Description | The company |
|---|---|---|
| Derivatives qualifying as cash flow hedges | Net of tax effect change in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges, after taxes, that is attributable to the parent entity. A cash flow hedge is a hedge of the exposure to variability in the cash flows of a recognized asset or liability or a forecasted transaction that is attributable to a particular risk. The change includes an entity's share of an equity investee's increase (decrease) in deferred hedging gains or losses. | Bristol-Myers Squibb Co.'s derivatives qualifying as cash flow hedges increased from 2015 to 2016 but then declined significantly from 2016 to 2017. |
| Pension and postretirement benefits | Net changes to accumulated comprehensive income during the period related to benefit plans, after tax, attributable to the parent entity. | Bristol-Myers Squibb Co.'s pension and postretirement benefits declined from 2015 to 2016 but then increased from 2016 to 2017 exceeding 2015 level. |
| Available-for-sale securities | Gross appreciation or the gross loss in value of the total unsold securities at the end of an accounting period, after tax, attributable to the parent entity. | Bristol-Myers Squibb Co.'s available-for-sale securities increased from 2015 to 2016 and from 2016 to 2017. |
| Foreign currency translation | Adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into functional currency of the reporting entity, net of tax, attributable to the parent entity. | Bristol-Myers Squibb Co.'s foreign currency translation increased from 2015 to 2016 and from 2016 to 2017. |
| Comprehensive income attributable to BMS | The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent. | Bristol-Myers Squibb Co.'s comprehensive income attributable to BMS increased from 2015 to 2016 but then declined significantly from 2016 to 2017. |
